The effect of caffeine consumption habits of contact tracing teams on anxiety, insomnia, and cardiac symptoms during the COVID-19 pandemic period
Main Article Content
Keywords
Keywords: Caffeine Consumption Habits, Anxiety, Insomnia, Cardiac Symptoms, Covid-19 Pandemic Period
Abstract
Purpose: The aim of this study was to examine the caffeine consumption habits and insomnia and anxiety levels of the personnel working in the contact tracing teams in the COVID-19 pandemic and to reveal their relationship with each other and with cardiac symptoms.Design and Methods: The population of this cross-sectional study consisted of the personnel working in contact tracing teams affiliated with a provincial health directorate. Data were collected with online questionnaire forms. There are questions intended for the descriptive characteristics, caffeine consumption habits, and cardiac symptoms of the participants, Beck Anxiety Inventory and Insomnia Severity Index in the questionnaire form consisting of three parts.Results: Mild anxiety was detected in 12.0% of the participants, and medium and severe anxiety in 23.6%. The insomnia rate in the participants was found to be 35.6%. A positive correlation was detected between the anxiety scores of the participants and insomnia scores and the number of cardiac symptoms; as their daily caffeine consumption increased, the anxiety, insomnia, and the number of cardiac symptoms increased as well. Practice Implications: Psychological support for healthcare professionals like the contact tracing team working with infected patients in the pandemic period must be ready to be given when necessary.
References
2. Bielicki JA, Duval X, Gobat N, et al. Monitoring approaches for health-care workers during the COVID-19 pandemic.The Lancet Infectious Diseases. 2020;20:10:261-7.
3. Fraser C, Riley S, Anderson RM, Ferguson NM.Factors that make an infectious disease outbreak controllable. Proceedings of the National Academy of Sciences. 2004;101.16: 6146-6151.
4. Demirtas T, Tekiner HJEMJ. Filiation: A historical term the COVID-19 outbreak recalled in Turkey. Erciyes Medical Journal. 2020;42(3):354-9.
5. Neil JF, Himmelhoch JM, Mallinger AG, Mallinger J, Hanin IJCp. Caffeinism complicating hypersomnic depressive episodes. Comprehensive psychiatry. 1978.
6. Bonita JS, Mandarano M, Shuta D, Vinson JJPr. Coffee and cardiovascular disease: in vitro, cellular, animal, and human studies. Pharmacological research. 2007;55(3):187-98.
7. O'Keefe JH, Bhatti SK, Patil HR, , et al. Effects of habitual coffee consumption on cardiometabolic disease, cardiovascular health, and all-cause mortality. J Am Coll Cardiol. 2013;62(12):1043-51.
8. Godos J, Pluchinotta FR, Marventano S,et al. Coffee components and cardiovascular risk: beneficial and detrimental effects.International journal of food sciences and nutrition.2014;65(8):925-36.
9. Staner LJDicn. Sleep and anxiety disorders. Dialogues in clinical neuroscience. 2003;5(3):249.
10. Barsky AJ, Delamater BA, Clancy SA, Antman EM, Ahern DK. Somatized psychiatric disorder presenting as palpitations. Archives of internal medicine.1996;156(10):1102-8.
11. Lipowski ZJ. Somatization and depression. Psychosomatics. 1990;31(1):13-21.
12. Ehlers A, Breuer PJJoap. Increased cardiac awareness in panic disorder. Journal of abnormal psychology. 1992;101(3):371.
13. Lipsitz JD, Masia-Warner C, Apfel H, et al. Anxiety and depressive symptoms and anxiety sensitivity in youngsters with noncardiac chest pain and benign heart murmurs. Journal of Pediatric Psychology. 2004;29(8):607-12.
14. Bastien CH, Vallières A, Morin CM. Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep medicine. 2001;2(4):297-307.
15. Boysan M, Gulec M, Besiroglu L, Kalafat T. Psychometric properties of the Insomnia Severity Index in Turkish sample. Anatolian Journal of Psychiatry.2010;11.3.
16. Beck AT, Epstein N, Brown G, Steer RAJJoc, psychology c. An inventory for measuring clinical anxiety: psychometric properties. Journal of consulting and clinical psychology. 1988;56(6):893.
17. Ulusoy M, Sahin NH, Erkmen HJJCP. The Beck anxiety inventory: psychometric properties. Journal of cognitive psychotherapy.1998;12(2):163-72.
18. Temsah M-H, Al-Sohime F, Alamro N, et al. The psychological impact of COVID-19 pandemic on health care workers in a MERS-CoV endemic country. Journal of infection and public health.2020. 13(6), 877-82.
19. Ömer A, SEZEROL MA, TAŞÇI Y, HAYRAN OJTHSD. COVID-19 pandemisinde görev yapan sağlık çalışanlarında anksiyete belirtileri ve uykusuzluk. Turkish Journal of Public Health.202018(Special issue):47-57.
20. Lai J, Ma S, Wang Y, et al. Factors associated with mental health outcomes among health care workers exposed to coronavirus disease 2019. JAMA Netw Open. 2020; 3 (3): e203976.
21. Magdalan J, Zawadzki M, Skowronek R, Czuba M,et al. Nonfatal and fatal intoxications with pure caffeine–report of three different cases. Forensic Science, Medicine and Pathology. 2017;13(3):355-8.
22. Lieberman HR, Tharion WJ, Shukitt-Hale B, Speckman KL, Tulley RJP. Effects of caffeine, sleep loss, and stress on cognitive performance and mood during US Navy SEAL training. Psychopharmacology. 2002;164(3):250-61.
23. Kochi AN, Tagliari AP, Forleo GB, Fassini GM, Tondo CJJoce. Cardiac and arrhythmic complications in patients with COVID‐19. Journal of cardiovascular electrophysiology. 2020;31(5):1003-8.
24. Gao W, Ping S, Liu XJJoad. Gender differences in depression, anxiety, and stress among college students: a longitudinal study from China. Journal of affective disorders. 2020;263:292-300.
25. Jahrami H, BaHammam AS, AlGahtani H, et al. The examination of sleep quality for frontline healthcare workers during the outbreak of COVID-19. Sleep and Breathing. 2020:1-9.
26. Taghizadeh F, Hassannia L, Moosazadeh M, et al. Anxiety and Depression in Health Workers and General Population During COVID-19 Epidemic in IRAN: A Web-Based Cross-Sectional Study. MedRxiv. 2020.
Article Sidebar
Article Details
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
